Subject: MJNA Up Early 10% On SA Blog

SCV Client Spotlight
MJNA Up Early 10% On SA Blog
Hot Stock to WatchHot Stock to Watch

Company:
Medical Marijuana Inc. (Pink Sheets: MJNA)


Last:

Price: 0.1692

Change (%): + 0.0152 (9.87)

Volume: 1,261,316
MJNA Chart

Medical Marijuana Inc. To Launch New Products

It's been a very exciting month for Medical Marijuana, Inc. (Pink Sheets: MJNA), with two super-spikes in the price precipitated by industry-wide news but both followed by steep and quick retreats. Traders, at least those on the right side of the wild action, love the volatility, and investors must be cheering the improving technicals and indications of promise ahead as the company hopefully capitalizes on growth in the medical marijuana sector. I recently shared my view of MJNA as a "Hold", suggesting a fair-value range of $0.10-.15. Today, I want to highlight some new offerings but also discuss a potential schism with its partner, Dixie Elixirs, which jointly owns Red Dice Holdings.

MJNA has beefed up its go-to-market efforts by establishing HempMedsPX, which is responsible not only for sales of its products to individuals but also into wellness centers. The company officially announced the change just 45 days ago, but the strategy was conceived earlier this year and included bringing in internet marketing veteran Charles Vest, Director of Communications, who has been increasing the outreach and awareness for the company's CBD-based products while also improving its sales capabilities as well as its communication. MJNA just relocated into larger headquarters to accommodate its increased sales staff. The jury is still out, but, in my opinion, this is a big step in the right direction.

HempMedsPX recently secured non-exclusive distribution rights for all of the products of CannaVest (CANV) through 2016, with exclusive online distribution rights as well. CANV was spun out of MJNA earlier this year and is a manufacturer of CBD-based products under license from MJNA, and MJNA has a substantial investment in CANV. The economics to MJNA aren't clear, as the compensation to HempMedsPX hasn't been disclosed.

Continue Reading

Like Us on FacebookFollow Us on Twitter

IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks